查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423230

2024-2032 年按產品類型、應用、最終用戶和地區分類的 DNA 定序產品市場報告

DNA Sequencing Products Market Report by Product Type, Application, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2023年全球DNA定序產品市場規模達69億美元。展望未來， IMARC Group預計到2032年市場規模將達到155億美元，2024-2032年複合年成長率（CAGR）為9%。人們對血統測試和譜系學的興趣日益濃厚，基於雲和人工智慧驅動的生物資訊解決方案的出現，DNA測序擴大融入無創產前測試和癌症診斷，以及學術機構、醫療保健提供者和醫療機構之間的合作不斷加強。生技公司是推動市場的一些因素。

DNA 定序產品是徹底改變遺傳學和分子生物學領域的尖端技術。這些產品能夠確定 DNA 分子中核苷酸的精確順序，為了解生物體的基因組成提供寶貴的見解。 DNA 定序在各種科學和醫學應用中發揮著至關重要的作用，包括基因研究、個人化醫療、法醫學和遺傳疾病研究。提供不同類型的 DNA 定序產品，從傳統的桑格定序到現代高通量次世代定序 (NGS) 平台。桑格定序作為先驅方法，仍適用於某些應用，而 NGS 則提供快速、經濟高效的高通量定序功能。這些產品不斷發展，不斷進步，從而提高了準確性、延長了讀取長度並降低了成本。因此，它們已成為各領域不可或缺的工具，推動突破性的發現，為精準醫學的進步和我們對生命遺傳基礎的理解做出貢獻。

DNA 定序技術的快速進步對市場做出了重大貢獻。特別是次世代定序 (NGS) 平台透過提供快速、高通量和經濟高效的定序功能，使該領域發生了革命性變化，使研究人員、臨床醫生甚至消費者更容易獲得 DNA 定序。此外，DNA 定序在不同領域的廣泛應用也促進了市場的成長。在研究中，DNA 定序用於探索各種生物體的基因組，從而在遺傳學、演化和疾病機制方面取得重大發現。 DNA 定序應用於醫療保健領域的個人化醫療、基因檢測和罕見遺傳疾病的診斷，從而促進了醫學界對這些產品的需求。此外，遺傳疾病的日益普及以及人們對基因檢測對於預防保健重要性的認知不斷提高，也推動了DNA定序產品的市場成長。法醫分析和農業作物改良中的 DNA 定序擴大了其市場範圍。此外，定序技術提供者和研究機構之間的合作和夥伴關係加速了產品的開發和採用。因此，定序準確性、讀長和資料分析能力的不斷提高催化了市場。此外，政府的措施、對基因組研究的資金支持以及 DNA 定序相關成本的降低，使這些產品更容易被更廣泛的受眾所使用，進一步刺激了市場擴張。

DNA 定序產品市場趨勢/促進因素：

慢性病和遺傳性疾病盛行率不斷上升

慢性病和遺傳性疾病盛行率的不斷上升已成為推動市場的重要因素。由於這些健康狀況持續影響全球很大一部分人口，因此越來越需要準確和早期的診斷，以促進有效的治療和管理。 DNA 定序對於識別與慢性疾病和失調相關的遺傳變異和突變至關重要。透過分析個人的 DNA，醫療保健專業人員可以找出導致這些疾病發展的特定遺傳因素，從而根據個人獨特的基因組成製定個人化的治療計劃。此外，隨著對疾病遺傳基礎的了解不斷深入，DNA 定序對於高風險個體的早期篩檢和預測測試變得至關重要。及早發現遺傳傾向使個人及其醫療保健提供者能夠採取積極措施來預防或減輕這些疾病的影響。隨著研究人員、臨床醫生和消費者認知到遺傳訊息在改變醫療保健和改善受慢性病和遺傳性疾病影響的患者預後方面的潛力，對這些產品的需求可能會繼續成長。

DNA 定序在藥物研究和藥物開發的應用不斷增加

DNA 定序在藥物研究和藥物開發中的日益普及正在推動市場發展。 DNA 定序為疾病的遺傳基礎和潛在治療標靶提供了寶貴的見解，徹底改變了藥物發現過程。借助下一代定序（NGS）技術，研究人員可以進行大規模基因組研究，並有效識別與特定疾病或藥物反應相關的遺傳變異。 DNA 定序能夠識別有助於患者分層的生物標記物，幫助製藥公司設計和進行更有針對性的臨床試驗。此外，DNA 定序有助於罕見疾病的研究和先前難以捉摸的新藥物標靶的發現。它使研究人員能夠以前所未有的詳細程度了解疾病的潛在分子機制，為精準醫學的發展鋪平道路。隨著製藥公司越來越認知到基因組學在藥物開發中的價值，對 DNA 測序產品的需求預計將繼續成長，在推進藥物研究和將創新療法推向市場方面發揮關鍵作用。

這些產品在農業的使用越來越多

DNA 定序產品在農業中的使用不斷增加推動了市場的成長。 DNA 定序技術能夠對農作物、牲畜和農業害蟲進行精確、有效率的基因組分析，徹底改變了農業產業。在作物改良中，DNA 定序對於識別與抗病性、產量潛力和營養成分等所需性狀相關的遺傳標記至關重要。這些資訊可幫助育種者透過標記輔助選擇開發新品種，加速育種過程並提高作物性能。 DNA 定序可幫助牲畜了解遺傳多樣性和育種計畫的潛力，以增強牲畜物種的理想性狀。反過來，這可以提高生產力並改善動物健康。此外，DNA 定序有助於研究農業害蟲和病原體，有助於制定有針對性的害蟲管理策略，減少有害化學物質的使用並促進永續農業。隨著農業部門尋求創新和有效的方法來提高生產力和永續性，對 DNA 定序產品的需求預計將進一步增加，從而推動農業進步並為全球糧食安全做出貢獻。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球 DNA 定序產品市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：依產品類型
  • 市場區隔：按應用
  • 市場區隔：按最終用戶
  • 市場區隔：按技術
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
    • 研究與開發
    • 原物料採購
    • 製造業
    • 分配
    • 最終用途
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第 6 章：市場區隔：依產品類型

  • 耗材和試劑
    • 市場走向
    • 市場預測
  • 裝置
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 生物標記
    • 市場走向
    • 市場預測
  • 診斷
    • 市場走向
    • 市場預測
  • 生殖健康
    • 市場走向
    • 市場預測
  • 法證學
    • 市場走向
    • 市場預測
  • 個人化醫療
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 學術和政府研究機構
    • 市場走向
    • 市場預測
  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 醫院和診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測

第 10 章：競爭格局

  • 市場結構
  • 市場區隔：按關鍵參與者
  • 關鍵參與者簡介
    • Illumina Inc
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Pacific Biosciences of California, Inc.
    • Beckman Coulter
Product Code: SR112024A839

Abstract

The global DNA sequencing products market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9% during 2024-2032. The increasing interest in ancestry testing and genealogy, the emergence of cloud-based and AI-driven bioinformatics solutions, the rising integration of DNA sequencing into non-invasive prenatal testing and cancer diagnostics, and the growing collaborations between academic institutions, healthcare providers, and biotechnology companies are some of the factors propelling the market.

DNA sequencing products are cutting-edge technologies that have revolutionized the field of genetics and molecular biology. These products enable the determination of the precise order of nucleotides in a DNA molecule, providing invaluable insights into the genetic makeup of organisms. DNA sequencing plays a crucial role in various scientific and medical applications, including gene research, personalized medicine, forensics, and the study of genetic diseases. Different types of DNA sequencing products are available, ranging from traditional Sanger sequencing to modern high-throughput Next-Generation Sequencing (NGS) platforms. Sanger sequencing, the pioneer method, remains relevant for certain applications, while NGS offers rapid, cost-effective, and high-throughput sequencing capabilities. These products are continually evolving, with advancements leading to improved accuracy, longer read lengths, and reduced costs. As a result, they have become indispensable tools in diverse fields, driving groundbreaking discoveries and contributing to advancements in precision medicine and our understanding of the genetic basis of life.

The rapid advancements in DNA sequencing technology are significantly contributing to the market. Next-Generation Sequencing (NGS) platforms, in particular, have revolutionized the field by providing rapid, high-throughput, and cost-effective sequencing capabilities, making DNA sequencing more accessible to researchers, clinicians, and even consumers. Furthermore, the expanding applications of DNA sequencing across diverse fields have contributed to market growth. In research, DNA sequencing is used to explore the genomes of various organisms, leading to significant discoveries in genetics, evolution, and disease mechanisms. DNA sequencing is employed in healthcare for personalized medicine, genetic testing, and diagnosis of rare genetic disorders, fostering demand for these products in the medical community. Moreover, the increasing prevalence of genetic diseases and the rising awareness of the importance of genetic testing for preventive healthcare have also fueled the market growth of DNA sequencing products. DNA sequencing in forensic analysis and agriculture for crop improvement has extended its market reach. Besides, collaborations and partnerships between sequencing technology providers and research institutions have accelerated product development and adoption. As a result, the continuous improvement in sequencing accuracy, read lengths, and data analysis capabilities have catalyzed the market. Additionally, the government's initiatives, funding support for genomic research, and decreasing costs associated with DNA sequencing have made these products more accessible to a broader audience, further stimulating market expansion.

DNA sequencing products Market Trends/Drivers:

Increasing prevalence of chronic diseases and genetic disorders

The increasing prevalence of chronic diseases and genetic disorders has become a significant factor catalyzing the market. As these health conditions continue to affect a large portion of the global population, there is a growing need for accurate and early diagnosis to facilitate effective treatment and management. DNA sequencing is crucial in identifying genetic variations and mutations associated with chronic diseases and disorders. By analyzing an individual's DNA, healthcare professionals can pinpoint specific genetic factors contributing to the development of these conditions, enabling personalized treatment plans based on a person's unique genetic makeup. Moreover, as the understanding of the genetic basis of diseases advances, DNA sequencing becomes essential in early screening and predictive testing for individuals at risk. Early detection of genetic predispositions empowers individuals and their healthcare providers to take proactive measures to prevent or mitigate the impact of these diseases. The demand for these products is likely to continue growing as researchers, clinicians, and consumers recognize the potential of genetic information in transforming healthcare and improving patient outcomes for those affected by chronic diseases and genetic disorders.

Rising adoption of DNA sequencing in pharmaceutical research and drug development

The rising adoption of DNA sequencing in pharmaceutical research and drug development is propelling the market. DNA sequencing has revolutionized the drug discovery process by providing invaluable insights into the genetic basis of diseases and potential therapeutic targets. With Next-Generation Sequencing (NGS) technologies, researchers can perform large-scale genomic studies and efficiently identify genetic variations associated with specific diseases or drug responses. DNA sequencing enables the identification of biomarkers that can aid in patient stratification, helping pharmaceutical companies design and conduct more targeted clinical trials. Additionally, DNA sequencing facilitates the study of rare diseases and the discovery of novel drug targets that were previously elusive. It allows researchers to understand the underlying molecular mechanisms of diseases at a level of detail never before possible, paving the way for the development of precision medicines. As pharmaceutical companies increasingly recognize the value of genomics in drug development, the demand for DNA sequencing products is expected to continue progressing, playing a pivotal role in advancing pharmaceutical research and bringing innovative therapies to the market.

Growing use of these products in agriculture

The growing use of DNA sequencing products in agriculture has driven the market growth. DNA sequencing technologies have revolutionized the agricultural industry by enabling precise and efficient genomic analysis of crops, livestock, and agricultural pests. In crop improvement, DNA sequencing is crucial in identifying genetic markers associated with desirable traits such as disease resistance, yield potential, and nutritional content. This information aids breeders in developing new varieties through marker-assisted selection, accelerating the breeding process and improving crop performance. DNA sequencing helps livestock understand the genetic diversity and potential for breeding programs to enhance desirable traits in livestock species. This, in turn, can lead to increased productivity and improved animal health. Furthermore, DNA sequencing is instrumental in studying agricultural pests and pathogens, enabling the development of targeted pest management strategies that reduce the use of harmful chemicals and promote sustainable agriculture. As the agricultural sector seeks innovative and efficient ways to enhance productivity and sustainability, the demand for DNA sequencing products is expected to increase further, driving advancements in agriculture and contributing to global food security.

DNA Sequencing Products Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global DNA sequencing products market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, application and end-user.

Breakup by Product Type:

Consumables and Reagents

Equipments

Consumables and reagents dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes consumables and reagents, and equipment. According to the report, consumables and reagents represented the largest segment.

The consumables and reagents encompass various essential components and materials for conducting DNA sequencing experiments and analysis. Consumables include items like DNA extraction kits, sequencing libraries, and flow cells, while reagents consist of chemical substances and enzymes required during the sequencing process. The significance of this market segment lies in its vital role in facilitating DNA sequencing procedures, making it a crucial investment for researchers, clinicians, and other users.

As DNA sequencing technologies evolve and advance, the demand for high-quality and specialized consumables and reagents augments, thereby contributing to the segment's substantial growth. Moreover, the consumables and reagents segment often enjoys a higher return on investment for manufacturers, as researchers and laboratories require regular restocking of these items to sustain their sequencing operations. As the DNA sequencing market expands, this segment is expected to maintain its dominance and contribute significantly to the overall revenue of the industry.

Breakup by Application:

Biomarkers

Diagnostics

Reproductive Health

Forensics

Personalized Medicine

Others

Biomarkers dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes biomarkers, diagnostics, reproductive health, forensics, personalized medicine, and others. According to the report, biomarkers represented the largest segment.

Biomarkers are specific genetic, biochemical, or molecular characteristics that provide valuable insights into an individual's health status and treatment response. In the realm of DNA sequencing, biomarkers hold immense importance, especially in personalized medicine. Biomarkers derived from DNA sequencing data aid in predicting treatment outcomes, enabling healthcare professionals to tailor therapies based on a patient's genetic profile. This personalized approach enhances treatment efficacy and minimizes adverse effects, optimizing patient outcomes.

The popularity of biomarkers in DNA sequencing products is driven by the increasing understanding of the link between genetics and disease, making them valuable tools in diagnostics, prognostics, and therapeutic decision-making. As the field of genomics continues to advance and more biomarkers are identified, the demand for DNA sequencing products, particularly those focused on biomarker analysis, is expected to grow significantly, further solidifying its prominent position in the market segment.

Breakup by End-User:

Academic and Government Research Institutes

Pharmaceutical and Biotechnology Companies

Hospitals and Clinics

Others

Academic and government research institutes dominate the market

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others. According to the report, academic and government research institutes represented the largest segment.

DNA sequencing products are currently experiencing significant utilization in academic and government research institutes. This trend can be attributed to the abundant research and development projects in these institutions that involve practical data analysis implementations and next-generation sequencing (NGS). Academic and government research institutes are at the forefront of scientific exploration. DNA sequencing plays a crucial role in various areas of study, including genomics, molecular biology, agriculture, and healthcare research.

The accessibility of advanced DNA sequencing technologies and the expertise of researchers in these institutions contribute to the widespread adoption of these products. Furthermore, these research institutes often collaborate with DNA sequencing companies, fostering partnerships that promote innovation and enhance product development. As a result, the demand for these products remains robust in the academic and government sectors, driving market growth and facilitating groundbreaking discoveries and advancements in scientific knowledge and applications.

Breakup by Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

North America exhibits a clear dominance, accounting for the DNA sequencing products largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market.

The North American region is dominant in the global market. This can be attributed to several key factors driving the market growth in the region. The region has a substantial geriatric population, leading to an increased demand for genetic testing and personalized medicine to address age-related health concerns. Furthermore, the prevalence of various chronic diseases in North America has bolstered the adoption of DNA sequencing products for diagnostics, prognosis, and treatment decision-making. DNA sequencing is vital in identifying genetic factors contributing to these diseases, enabling targeted therapies and precision medicine approaches. Moreover, the region has several prominent drug manufacturers and biotechnology companies actively involved in genomic research and drug development. The presence of such industry players drives the demand for these products to support their research and clinical trials.

Competitive Landscape:

Top companies are bolstering market growth through several strategic approaches. They invest heavily in research and development to continuously improve their sequencing technologies, enhancing accuracy and scalability and reducing costs. This ensures that their products remain at the forefront of innovation and appeal to a broader customer base. Furthermore, these companies actively collaborate with academic institutions, research organizations, and healthcare providers to expand their customer reach and foster partnerships that drive product development and application. Additionally, they focus on expanding their product portfolios to cater to various customer needs, offering a range of DNA sequencing solutions tailored for different applications and industries. Moreover, effective marketing strategies, including targeted advertising, educational campaigns, and endorsements from key opinion leaders, create awareness and drive demand for their products. By employing these strategies and staying at the forefront of technological advancements, the top companies propel market growth and play a pivotal role in advancing genomics research, healthcare, agriculture, and other fields.

The report has provided a comprehensive analysis of the competitive landscape in the DNA sequencing products market. Detailed profiles of all major companies have also been provided.

Illumina Inc.

Thermo Fisher Scientific Inc.

F. Hoffmann-La Roche Ltd.

Pacific Biosciences of California, Inc.

Beckman Coulter

Recent Developments:

In 2019, Illumina announced a collaboration with Bristol-Myers Squibb to develop companion diagnostics for oncology treatments. The companies aimed to leverage Illumina's sequencing technology to identify genomic biomarkers that could help predict patient responses to specific cancer therapies.

In 2019, Thermo Fisher Scientific partnered with West China Hospital of Sichuan University to establish a Joint Precision Medicine Research Laboratory in China. The collaboration aimed to advance precision medicine research by integrating Thermo Fisher's genetic sequencing solutions with the hospital's clinical expertise.

In 2018, Roche announced a collaboration with Foundation Medicine, Inc. to develop and distribute FoundationOne CDx, a comprehensive genomic profiling assay. The collaboration aimed to expand access to comprehensive genomic testing for cancer patients and guide personalized treatment decisions.

Key Questions Answered in This Report

  • 1. What was the size of the global DNA sequencing products market in 2023?
  • 2. What is the expected growth rate of the global DNA sequencing products market during 2024-2032?
  • 3. What are the key factors driving the global DNA sequencing products market?
  • 4. What has been the impact of COVID-19 on the global DNA sequencing products market?
  • 5. What is the breakup of the global DNA sequencing products market based on the product type?
  • 6. What is the breakup of the global DNA sequencing products market based on the application?
  • 7. What is the breakup of the global DNA sequencing products market based on the end-user?
  • 8. What are the key regions in the global DNA sequencing products market?
  • 9. Who are the key players/companies in the global DNA sequencing products market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global DNA Sequencing Products Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Application
  • 5.6 Market Breakup by End-User
  • 5.7 Market Breakup by Technology
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
    • 5.11.1 Research and Development
    • 5.11.2 Raw Material Procurement
    • 5.11.3 Manufacturing
    • 5.11.4 Distribution
    • 5.11.5 End-Use
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product Type

  • 6.1 Consumables and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Biomarkers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Reproductive Health
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Forensics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Personalized Medicine
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Academic and Government Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Market Breakup by Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Illumina Inc
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 Thermo Fisher Scientific Inc.
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 F. Hoffmann-La Roche Ltd.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Pacific Biosciences of California, Inc.
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Beckman Coulter
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio
      • 10.3.5.4 Financials
      • 10.3.5.5 SWOT Analysis

List of Figures

  • Figure 1: Global: DNA Sequencing Products Market: Major Drivers and Challenges
  • Figure 2: Global: DNA Sequencing Products Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: DNA Sequencing Products Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: DNA Sequencing Products Market: Breakup by Application (in %), 2023
  • Figure 5: Global: DNA Sequencing Products Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: DNA Sequencing Products Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: DNA Sequencing Products Market: Breakup by Region (in %), 2023
  • Figure 8: Global: DNA Sequencing Products Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: DNA Sequencing Products Industry: SWOT Analysis
  • Figure 10: Global: DNA Sequencing Products Industry: Value Chain Analysis
  • Figure 11: Global: DNA Sequencing Products Industry: Porter's Five Forces Analysis
  • Figure 12: Global: DNA Sequencing Products Market: Consumables and Reagents (in Million US$), 2018 & 2023
  • Figure 13: Global: DNA Sequencing Products Market Forecast: Consumables and Reagents (in Million US$), 2024-2032
  • Figure 14: Global: DNA Sequencing Products Market: Equipments (in Million US$), 2018 & 2023
  • Figure 15: Global: DNA Sequencing Products Market Forecast: Equipments (in Million US$), 2024-2032
  • Figure 16: Global: DNA Sequencing Products Market (Applications in Biomarkers): Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: DNA Sequencing Products Market Forecast (Applications in Biomarkers): Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: DNA Sequencing Products Market (Applications in Diagnostics): Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: DNA Sequencing Products Market Forecast (Applications in Diagnostics): Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: DNA Sequencing Products Market (Application in Reproductive Health): Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: DNA Sequencing Products Market Forecast (Applications in Reproductive Health): Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: DNA Sequencing Products Market (Applications in Forensics): Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: DNA Sequencing Products Market Forecast (Applications in Forensics): Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: DNA Sequencing Products Market (Applications in Personalized Medicine): Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: DNA Sequencing Products Market Forecast (Applications in Personalized Medicine): Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: DNA Sequencing Products Market (Other Applications): Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: DNA Sequencing Products Market Forecast (Other Applications): Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: DNA Sequencing Products Market (in Academic and Government Research Institutes): Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: DNA Sequencing Products Market Forecast (in Academic and Government Research Institutes): Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: DNA Sequencing Products Market (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: DNA Sequencing Products Market Forecast (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: DNA Sequencing Products Market (in Hospitals and Clinics): Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: DNA Sequencing Products Market Forecast (in Hospitals and Clinics): Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: DNA Sequencing Products Market (Other End-Users): Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: DNA Sequencing Products Market Forecast (Other End-Users): Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Europe: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Europe: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia Pacific: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia Pacific: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Latin America: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Latin America: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Middle East and Africa: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Middle East and Africa: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: DNA Sequencing Products Market: Breakup by Key Players (in %), 2023

List of Tables

  • Table 1: Global: DNA Sequencing Products Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: DNA Sequencing Products Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: DNA Sequencing Products Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: DNA Sequencing Products Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: DNA Sequencing Products Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: DNA Sequencing Products Market: Competitive Structure
  • Table 7: Global: DNA Sequencing Products Market: Key Players